MedX Launches Strategic Artificial Intelligence Initiative
Summary
MISSISSAUGA, Ontario--( BUSINESS WIRE )--MedX Health Corp. (“MedX”) (TSX-V: MDX) announces that it is initiating the development of an Artificial Intelligence Engine with leading dermatologists and its technology partner, Blanc Labs, that will work in conjunction with its existing DermSecure TM screening platform.MedX has been working closely with its Scientific Medical Advisory Board (“SMAB”) to launch an AI strategy that will complement DermSecure TM and current assessment protocols.With the increase of data size, over time, the Deep Learning algorithm will enable the platform to deliver a highly accurate assessment tool to Dermatologists, and we are very excited to continue innovating with MedX, pushing the boundaries, and making an impact on the early detection of skin cancer.”MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin cancer with its DermSecure™ telemedicine platform, utilizing its SIAscopy technology.MedX also designs, manufactures and distributes quality photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain.